drugset / Trial / NCT07281677
Immunogenicity and Safety of Sequential 2vHPV-9vHPV Vaccination in Girls Aged 9-14 Years
Phase 4
Active not recruiting
400 enrolled
Zhejiang Provincial Center for Disease Control and Prevention
RandomizedSequentialOpen-labelPrevention
Summary
This study aims to assess the immunogenicity and safety of a sequential 2vhpv to 9vhpv immunization schedule in girls aged 9-14 years
Timeline
- Start
- 2025-12-20
- Primary completion
- 2028-12-20
- Completion
- 2029-11-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cervarix | Vaccine | — | — |
| Subject | Gardasil 9 | Vaccine | — | — |